Tci Wealth Advisors, Inc. Sesen Bio, Inc. Transaction History

Tci Wealth Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$0.38 - $0.89 $228 - $534	-600 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$0.73 - $1.28 $438 - $768	600 New	600 $0
Q2 2019 Jul 23, 2019	SELL	$0.95 - $2.46 $1,140 - $2,952	-1,200 Closed	0 $0
Q1 2019 Apr 11, 2019	BUY	$0.69 - $1.47 $482 - $1,029	700 Added 140.0%	1,200 $1,000
Q4 2018 Jan 17, 2019	SELL	$0.96 - $2.04 $96 - $204	-100 Reduced 16.67%	500 $1,000
Q3 2018 Nov 02, 2018	BUY	$1.54 - $2.38 $924 - $1,428	600 New	600 $1,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.